Search

Craig D. Ricci

Examiner (ID: 10445, Phone: (571)270-5864 , Office: P/1628 )

Most Active Art Unit
1628
Art Unit(s)
1611, 1628, 1614
Total Applications
1547
Issued Applications
760
Pending Applications
153
Abandoned Applications
681

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18529919 [patent_doc_number] => 20230234986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => INHIBITORS OF CORONAVIRUS PROTEASE [patent_app_type] => utility [patent_app_number] => 17/926892 [patent_app_country] => US [patent_app_date] => 2021-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8778 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926892 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/926892
INHIBITORS OF CORONAVIRUS PROTEASE Apr 29, 2021 Pending
Array ( [id] => 18355005 [patent_doc_number] => 11643394 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-09 [patent_title] => Kruppel-like factor 15 (KLF15) small molecule agonists in kidney disease [patent_app_type] => utility [patent_app_number] => 17/244762 [patent_app_country] => US [patent_app_date] => 2021-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 53 [patent_no_of_words] => 45644 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17244762 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/244762
Kruppel-like factor 15 (KLF15) small molecule agonists in kidney disease Apr 28, 2021 Issued
Array ( [id] => 17020857 [patent_doc_number] => 20210244728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => Method of treating peripheral neuropathy [patent_app_type] => utility [patent_app_number] => 17/243092 [patent_app_country] => US [patent_app_date] => 2021-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6751 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17243092 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/243092
Method of treating peripheral neuropathy Apr 27, 2021 Abandoned
Array ( [id] => 17241855 [patent_doc_number] => 20210361598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-25 [patent_title] => COMPOUNDS FOR PREVENTION AND TREATMENT OF POST-INTENSIVE CARE COGNITIVE DYSFUNCTION AND COGNITIVE DYSFUNCTION RESULTING FROM RESPIRATORY DISTRESS [patent_app_type] => utility [patent_app_number] => 17/242755 [patent_app_country] => US [patent_app_date] => 2021-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17998 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242755 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/242755
COMPOUNDS FOR PREVENTION AND TREATMENT OF POST-INTENSIVE CARE COGNITIVE DYSFUNCTION AND COGNITIVE DYSFUNCTION RESULTING FROM RESPIRATORY DISTRESS Apr 27, 2021 Pending
Array ( [id] => 18374274 [patent_doc_number] => 20230149352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => USES OF APREMILAST [patent_app_type] => utility [patent_app_number] => 17/920602 [patent_app_country] => US [patent_app_date] => 2021-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6425 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920602 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/920602
USES OF APREMILAST Apr 20, 2021 Pending
Array ( [id] => 19164755 [patent_doc_number] => 11980637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-14 [patent_title] => Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy [patent_app_type] => utility [patent_app_number] => 17/233802 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12146 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233802 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/233802
Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy Apr 18, 2021 Issued
Array ( [id] => 17943553 [patent_doc_number] => 20220330570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => METHOD AND SYSTEM FOR MANUFACTURING CHILL POPS [patent_app_type] => utility [patent_app_number] => 17/231378 [patent_app_country] => US [patent_app_date] => 2021-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2377 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231378 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/231378
METHOD AND SYSTEM FOR MANUFACTURING CHILL POPS Apr 14, 2021 Abandoned
Array ( [id] => 17355349 [patent_doc_number] => 20220016145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND OTHER DISORDERS [patent_app_type] => utility [patent_app_number] => 17/222662 [patent_app_country] => US [patent_app_date] => 2021-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18755 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222662 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/222662
Compositions and methods for treating muscular dystrophy and other disorders Apr 4, 2021 Issued
Array ( [id] => 18232072 [patent_doc_number] => 11596614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-03-07 [patent_title] => Treatment of intrahepatic cholestatic diseases [patent_app_type] => utility [patent_app_number] => 17/221784 [patent_app_country] => US [patent_app_date] => 2021-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4280 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221784 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/221784
Treatment of intrahepatic cholestatic diseases Apr 2, 2021 Issued
Array ( [id] => 20301268 [patent_doc_number] => 12447238 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-21 [patent_title] => Antimicrobial tubular conduits [patent_app_type] => utility [patent_app_number] => 17/907290 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 6293 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907290 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/907290
Antimicrobial tubular conduits Mar 25, 2021 Issued
Array ( [id] => 18449452 [patent_doc_number] => 20230190728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => NEW THERAPEUTIC USES OF COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/913379 [patent_app_country] => US [patent_app_date] => 2021-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29831 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913379 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/913379
NEW THERAPEUTIC USES OF COMPOUNDS Mar 24, 2021 Pending
Array ( [id] => 18595333 [patent_doc_number] => 20230270121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => NOVEL ORGANIC FUNGICIDE [patent_app_type] => utility [patent_app_number] => 18/006701 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5298 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006701 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/006701
NOVEL ORGANIC FUNGICIDE Mar 18, 2021 Pending
Array ( [id] => 18018921 [patent_doc_number] => 20220370420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => SPIROCYCLIC 2,3-DIHYDRO-7-AZAINDOLE COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/204089 [patent_app_country] => US [patent_app_date] => 2021-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 97291 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204089 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/204089
Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof Mar 16, 2021 Issued
Array ( [id] => 18315087 [patent_doc_number] => 11629156 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-18 [patent_title] => 7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors [patent_app_type] => utility [patent_app_number] => 17/202867 [patent_app_country] => US [patent_app_date] => 2021-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17155 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202867 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/202867
7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors Mar 15, 2021 Issued
Array ( [id] => 16991765 [patent_doc_number] => 20210230185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => 7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AS MUTANT IDH1 AND IDH2 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/202515 [patent_app_country] => US [patent_app_date] => 2021-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202515 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/202515
7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors Mar 15, 2021 Issued
Array ( [id] => 18383327 [patent_doc_number] => 11654091 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-05-23 [patent_title] => Hydrophobic topical lotion for swimmers to reduce friction when swimming [patent_app_type] => utility [patent_app_number] => 17/202061 [patent_app_country] => US [patent_app_date] => 2021-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3049 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202061 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/202061
Hydrophobic topical lotion for swimmers to reduce friction when swimming Mar 14, 2021 Issued
Array ( [id] => 17385494 [patent_doc_number] => 20220033346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => METHODS OF TREATING FIBROSIS [patent_app_type] => utility [patent_app_number] => 17/199860 [patent_app_country] => US [patent_app_date] => 2021-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12466 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199860 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/199860
Methods of treating fibrosis Mar 11, 2021 Issued
Array ( [id] => 16945855 [patent_doc_number] => 20210204546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => RERBICIDES [patent_app_type] => utility [patent_app_number] => 17/194537 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14938 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 206 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194537 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/194537
RERBICIDES Mar 7, 2021 Abandoned
Array ( [id] => 16913775 [patent_doc_number] => 20210186867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => DRUG DELIVERY SYSTEM FOR THE DELIVERY OF ANTIVIRAL AGENTS [patent_app_type] => utility [patent_app_number] => 17/193493 [patent_app_country] => US [patent_app_date] => 2021-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17193493 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/193493
DRUG DELIVERY SYSTEM FOR THE DELIVERY OF ANTIVIRAL AGENTS Mar 4, 2021 Abandoned
Array ( [id] => 17065838 [patent_doc_number] => 20210268053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => FAT ABSORPTION INHIBITING AGENT, FOOD AND DEFATTED SESAME SEEDS, AND METHOD FOR INHIBITING OBESITY [patent_app_type] => utility [patent_app_number] => 17/183646 [patent_app_country] => US [patent_app_date] => 2021-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6124 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17183646 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/183646
Fat absorption inhibiting agent, food and defatted sesame seeds, and method for inhibiting obesity Feb 23, 2021 Issued
Menu